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Abstract
The use of national inpatient databases for orthopaedic surgery research has been
increasing. However, large databases that rely on administrative data, such as
International Classification of Diseases Ninth Revision (ICD-9) codes, may misrepresent
patient information, thus affecting the results of studies using this data.
The present study uses easily quantified and objective variables of obesity and
anemia as example comorbidities to assess the accuracy of ICD-9 codes in the setting of
their continued use in orthopaedic surgery database studies.
For each study arm, a large inpatient population was obtained from the Yale-New
Haven hospital. Each patient’s medical record was reviewed, and the presence of ICD-9
discharge codes for obesity and anemia was directly compared to documented body mass
index (BMI) and preoperative hematocrit, respectively.
ICD-9 discharge codes for both non-morbid obesity and anemia had a sensitivity
of just 0.19. The sensitivity of the ICD-9 code for morbid obesity was 0.48.
Using obesity and anemia as examples, this study highlights the potential errors
inherent to ICD-9 codes. This calls into serious question the utility of administrative
databases for research purposes. Moreover, it is likely that these inaccuracies apply to
additional variables as well. As database research continues to increase within
orthopaedic surgery, it is important to realize that study outcomes can be skewed by data
accuracy, and thus should not be blindly accepted simply by virtue of large sample sizes.
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Introduction
Recently, the use of large national inpatient databases for orthopaedic surgery
research has increased significantly. While databases differ in their methods of data
collection and verification, many such databases are constructed upon hospital
reimbursement claims data such as the International Classification of Diseases, Ninth
Revision (ICD-9) codes. Unfortunately, due to the wide variety of styles, without a
working knowledge of each major database, it can be difficult for the practicing physician
to discern whether a given study presents valid results to the specific questions being
asked.
Many ICD-9-coded databases are currently available, including the Nationwide
Inpatient Sample (NIS), the Nationwide Emergency Department Sample (NEDS), the
National Hospital Discharge Survey (NHDS), and several additional private insurance
databases available through for-profit distributors. Several have reached tremendous size.
The NIS reports that each year of data consists of approximately 8 million hospital stays
from over 1,000 hospitals.1 Similarly, the NEDS contains approximately 130 million total
emergency department visits.2
Other databases, including the National Surgical Quality Improvement Program
database maintained by the American College of Surgeons (ACS-NSQIP), are instead
built from direct chart data acquisition rather than from administrative ICD-9 coding;
however, this method is currently used less often for assembling national databases due to
increased costs and logistical barriers. In such patient data registry databases, patient
information is abstracted in real time by trained clinical staff from the patient chart
directly into the database. In the case of the ACS-NSQIP database, this process is
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carefully regulated and continually monitored with an Inter-Rater Reliability (IRR) Audit
of randomly selected sites. These IRR Audits exist to ensure high quality data that
consistently exhibits an inter-rater disagreement of less than 2%, with an absolute upper
limit of 5% disagreement.3
The relatively recent widespread availability of databases has generated a new
avenue by which to address a multitude of research questions in medicine, and more
specifically, in orthopaedic surgery. The large sample sizes dwarf what could otherwise
be obtained by any single hospital system or study group, creating an attractive resource
for estimating disease prevalence, healthcare utilization, and outcomes from across the
nation. Additionally, these tremendous sample sizes permit, for the first time, a method
by which to evaluate rare conditions, uncommon treatments, and subset populations at a
large scale.1
However, it is important to understand the many established limitations to using
patient databases in medical research. First, the majority of these databases are assembled
solely from inpatient data. This method samples an inherently sicker proportion of the
population, which puts substantial limits on the applicability of any findings to the
general population. Moreover, and crucial to the understanding of administrative database
limitations, is the fact that ICD-9 data is generally abstracted from medical provider notes
for reimbursement purposes. Because this relies on both the input of the provider and the
careful extraction of data by the coding professional, this system is prone to omission of
details and thus may not accurately represent the entire patient.4,5 Furthermore, it has
been demonstrated previously that significant heterogeneity can exist among large
databases due to variations in unknown patient variables. A recent meta-analysis found
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that because of this heterogeneity, 20-40% of all observational database studies could
swing from being statistically significant in one direction to being statistically significant
in the opposite direction, purely based on choice of database.6 This finding highlights the
particular importance of carefully choosing a database most suitable for the research
question at hand.
To follow up on these past results, our research group conducted two studies
comparing the NIS, an administratively-coded database, with the ACS-NSQIP, a patient
registry database. In the first study, we extracted an analogous group of lumbar fusion
patients during the years 2009-2011 from each of the two databases.7 We then proceeded
to compare the demographics, length of stay, comorbidities, and inpatient adverse events
between these two groups. The purpose was to get a sense of the overall relationship
between ICD-9 codes and clinical reality.
With regards to patient demographics and length of stay, we found that these
factors were quite similar between the two databases.7 However, with regards to adverse
events, we found that the rates of sepsis and cardiac arrest in lumbar fusion patients were
more than two-fold higher in the ACS-NSQIP compared to the NIS, while conversely,
the rates of acute kidney injury (AKI) and urinary tract infection (UTI) were more than
two-fold higher in the NIS compared to the ACS-NSQIP. Furthermore, in terms of the
comorbidity variables examined, obesity was more than twice as common in NSQIP
patients than it was in NIS patients, with the reverse holding true for the incidence of
peripheral vascular disease.
This study was then performed again, only this time comparing two analogous
populations of patients undergoing operative stabilization of transcervical and
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intertrochanteric hip fractures from the NSQIP and NIS databases.8 We again found that
demographics and length of stay were similar between groups. Additional findings
continued to be strikingly similar to our previous study in lumbar fusion patients, as the
incidences of AKI and UTI were again two-fold higher in NIS compared to NSQIP.
Similarly, the rate of obesity was more than two-fold higher in NSQIP compared to NIS,
only this time obesity was accompanied by anemia and coagulopathy in this finding.
By comparing one national database constructed purely on ICD-9 codes to a
different national database built from direct chart data, these studies shed important light
on the overall landscape of ICD-9 coding accuracy. While the populations were found to
be nearly demographically identical, it is worrisome to note how divergent many of the
rates of inpatient adverse events and comorbidities were between groups. From this
advantageous vantage point generated by these initial studies, we endeavor to direct our
focus to a more granular examination of the specifics of ICD-9 coding and its potential
flaws.
Several previous studies have noted the inaccuracies of ICD-9 discharge codes in
various different medical and surgical populations.9-19 One such study sought to evaluate
the ability of ICD-9 codes to identify cardiovascular and stroke risk factors in Medicare
patients with atrial fibrillation, such as arterial peripheral embolus, heart failure,
stroke/TIA, coronary heart disease, diabetes, and hypertension.14 Of the nine conditions
evaluated, no condition had a sensitivity of greater than 76%, with the lowest sensitivity
at 20%, and a mean sensitivity of 54%. A similar study evaluated ICD-9 codes related to
stroke and stroke risk factors, finding sensitivities ranging from 7% for tobacco use, to
28% for history of cerebrovascular accident, to 91% for diabetes.16 Finally, a third
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previous study looked at the ability of ICD-9 codes to accurately identify thirty-two
different conditions. These results varied from a sensitivity of just 1% for postural
hypotension, to 27.6% for peptic ulcers, to 68.7% for hypertension.19 While these prior
investigations cover a wide breadth of subject matter, a common thread among these
studies is the tremendous variability in ICD-9 coding accuracies, as well as the
unpredictable nature of which conditions will be well coded versus those that will be
poorly coded.
More specifically, some previous studies have examined the relationship between
ICD-9 codes and obesity. A 2012 study in obstetric patients compared multiple ICD-9
codes to patient chart data and found widely variable coding accuracies among
comorbidities such as hemorrhage, infection, and obesity.20 For obesity, ICD-9 codes
correctly identified just 15% of obese patients. Similarly, three studies have examined the
difficulties of diagnosing obesity in a pediatric population that include, but are not limited
to, body mass index (BMI) cutoffs that change both with age and gender.21-23 These
studies found ICD-9 codes for pediatric obesity to be only 7.0-8.3% accurate.
While these prior works provide much thought-provoking groundwork about the
potentially poor sensitivity of various ICD-9 codes, the current study endeavors to build
upon this foundation and further delineate how ICD-9 codes reflect clinical reality for a
given diagnosis in orthopaedic surgery patients. Prior investigations were conducted in
specialized patient populations that may have their own inherent considerations not
readily generalizable to adult orthopaedic surgery populations. Moreover, ICD-9 coding
issues were largely examined either as secondary outcomes or as one of many other
questions being addressed.
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With previous investigations as a valuable foundation, there remains a clear need
to directly analyze how ICD-9 codes relate to clinical reality. The current study uses the
variables of obesity and anemia to present individual illustrative examples that we
anticipate will be widely applicable to many further comorbidities and patient factors that
are commonly documented in national administrative inpatient databases. Obesity and
anemia were chosen because they are easily quantifiable, continuous variables with wellestablished BMI and hematocrit designations, respectively. Moreover, each of these
variables was recently found to be undercoded in the ICD-9-coded NIS database
compared to the specifically abstracted patient registry ACS-NSQIP database.7,8 Finally,
obesity and anemia are used ubiquitously in large orthopaedic surgery database research,
both as comorbidities in multivariable analyses and predictors of clinical outcomes.24-27
The current study consists of two separate, but related, arms. In each case, we
employed a large inpatient population to explore the accuracy of ICD-9 coding. This was
done by comparing the chart documentation of a specific patient entity to whether or not
that variable was captured via the ICD-9 codes assigned to the patient upon discharge.
For obesity, the specific patient entity used in this study was BMI, while for anemia the
specific patient entity was preoperative hematocrit. These are the very codes that are used
to construct large national administrative databases, such as the NIS and NEDS. We
hypothesize that ICD-9 codes underestimate true rates of obesity and anemia, potentially
to such a degree that they may sway the results of studies using ICD-9 coded databases
for research purposes.
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Methods
In each arm of this investigation, we conducted a cross-sectional study comparing
each patient’s ICD-9 discharge codes to chart-documented patient variables. This
variable was obesity (based on BMI) in the first arm and anemia (based on hematocrit) in
the second arm. All chart data acquisition and analysis was performed by myself.

Obesity
For the portion of this work that focused on obesity, we obtained a sixteen-day
inpatient cohort from the Yale-New Haven Hospital. This included all patients over 18
years of age who spent at least one night in the hospital between April 1 and April 16,
2013. Patients from Obstetrics & Gynecology, Psychiatry, and Pediatrics were excluded,
as it was reasoned that these patients can be subject to irregular or inaccurate weights,
whether due to physiology or pharmaceuticals.
Following approval from the Yale University Human Investigations Committee,
patient data was collected from the electronic medical record. Beyond demographic data,
the patients’ discharge height (inches) and weight (pounds) were collected, along with all
assigned primary and secondary ICD-9 diagnosis codes. For patients without a recorded
discharge height and weight, the values recorded closest to discharge were used.
BMI was calculated using the formula BMI = 703 x (weight (lb) / [height
(in)*height (in)]).28 Standard BMI classifications were used, with a BMI of less than 30
kg/m2 as non-obese, a BMI of 30-39.9 kg/m2 as obese, and a BMI of 40 kg/m2 and above
as morbidly obese.29 For ease of terminology, the rest of the paper refers to a BMI of 30-
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39.9 kg/m2 as “non-morbid obesity” and a BMI at or above 40 kg/m2 as “morbid
obesity.”
ICD-9 codes were then evaluated, with the code of 278.00 designated for
“Obesity, unspecified” and the code of 278.01 for “Morbid obesity.”30 The presence of
ICD-9 code 278.00 was compared to patients with a calculated BMI between 30 and
39.9, while 278.01 was compared to patients with a BMI that was greater than 40. These
comparisons are consistent with prior studies utilizing ICD-9-based databases. On
occasion, comorbidities such as obesity are captured using secondary ICD-9 codes. The
secondary ICD-9 codes of V85.3 (BMI 30-39.9) and V85.4 (BMI 40 and above) exist to
attempt to capture a patient’s specific BMI, rather than a BMI range. These secondary
codes were included in a separate analysis.

Anemia
In the portion of this research investigating anemia, we used a large population of
patients who had undergone cervical or lumbar fusion surgery. This population was
chosen because these patients are universally required to obtain a preoperative
hemoglobin and hematocrit level due to the risk of blood loss associated with spine
surgery. This population was retrospectively collected from Yale-New Haven Hospital
and included all patients who underwent either cervical or lumbar fusion between
February 1, 2013 and December 31, 2013. Patients either without a documented
preoperative complete blood count (CBC) or who underwent fusion as a result of trauma
were excluded.
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This anemia arm of the study was also approved by the Yale University Human
Investigations Committee. Patient data was abstracted from the electronic medical record
and included demographics, preoperative hematocrit, and all assigned primary and
secondary ICD-9 diagnosis codes. Standard classifications of anemia were used to
determine the prevalence of preoperative anemia in the current study population: anemia
in a female was defined as a hematocrit of less than 36.0%, and anemia in a male was
defined as a hematocrit of less than 41.0%.31
ICD-9 codes were then evaluated based on the batch of ICD-9 codes that are
grouped together to be used for the NIS database definition of the comorbidity
“deficiency anemia.” These codes, determined by the NIS, are as follows: 280.1 (Iron
Deficiency Anemia Secondary to Inadequate Dietary Iron Intake), 280.8 (Other Specified
Iron Deficiency Anemias), 280.9 (Iron Deficiency Anemia Unspecified), 281.0
(Pernicious Anemia), 281.1 (Other Vitamin B12 Deficiency Anemia), 281.2 (FolateDeficiency Anemia), 281.3 (Other Specified Megaloblastic Anemias Not Elsewhere
Classified), 281.4 (Protein-Deficiency Anemia), 281.8 (Anemia Associated with Other
Specified Nutritional Deficiency, 281.8 (Anemia Associated with Other Specified
Nutritional Deficiency), 281.9 (Unspecified Deficiency Anemia), 285.21 (Anemia in
Chronic Kidney Disease), 285.22 (Anemia in Neoplastic Disease), 285.29 (Anemia of
Other Chronic Disease), and 285.9 (Anemia Unspecified).32,33
Because this NIS variable is designed to capture anemia as a comorbidity upon
entry to the hospital, this designation excludes patients who experienced any sort of acute
blood loss as a result of their surgery or hospital stay. For similar reasons, we compared
the presence of these codes to a given patient’s preoperative hematocrit, rather than a
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hematocrit taken during the hospital stay, so as to most closely approximate the anemia
status of the patient upon entry to the hospital. This is consistent with the manner in
which current studies investigating the relationship between spinal pathologies and
anemia in the NIS use the “deficiency anemia” variable.34-42

Statistical Methods
Data analyses and organization were performed by the study authors using Stata®
version 13.0 (StataCorp, LP, College Station, Texas, USA).

Results
Obesity
During the sixteen-day study period, there were 2,115 adult patients identified
who spent at least one inpatient night in the hospital. 40 (1.9%) were excluded for
missing either a height or weight in the medical record, leaving 2,075 patients for
analysis.
Patient demographics can be found in Table 1. The average patient age was 59.6 ±
18.5 years (mean ± standard deviation [SD]) and 50.2% of patients in this cohort were
female.
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Table 1: Demographics of the patient population for the obesity arm of the present study
Overall
Sex
Female
Male
Age
18-39
40-49
50-59
60-69
70-79
80+
Body Mass Index
10-19.9 [Not Obese]
20-29.9 [Not Obese]
30-39.9 [Non-Morbid Obesity]
40-49.9 [Morbid Obesity]
50-59.9 [Morbid Obesity]
60-69.9 [Morbid Obesity]
70-80.0 [Morbid Obesity]

Number
2,075

Percent
100%

1,043
1,032

50.3%
49.7%

297
295
415
407
340
321

14.3%
14.2%
20.0%
19.6%
16.4%
15.5%

169
1,159
573
130
29
11
4

8.1%
55.9%
27.6%
6.3%
1.4%
0.5%
0.2%

The calculated BMI distribution is shown by BMI decile in Table 1 and by total
column height in Figure 1a. The average calculated BMI was 28.9 ± 7.9 kg/m2. Overall,
1,328 patients (64.0%) had a BMI less than 30 (non-obese), 573 patients (27.6%) had a
BMI between 30 and 39.9 (non-morbid obesity), and 174 patients (8.4%) had a BMI of
40 or above (morbid obesity). When non-morbid and morbid obesity patients were
combined, a total of 747 (36.0%) were categorized as being obese in some fashion (BMI
≥ 30).
Patients were then subdivided based on ICD-9 coding data. They are shown
matched to chart-documented BMI calculations as sections of columns for each BMI
decile in Figure 1a and subsequently by percent of patients for a given BMI decile in
Figure 1b.
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From 156 patients who received the “obesity” ICD-9 code of 278.00, 109 had a
true BMI between 30 and 39.9, while 47 had miscoded BMIs outside of this range
(Figure 1). 15 miscoded patients had a BMI below 30, and 32 had a BMI above 40. Thus,
only 109 of the 573 patients (19.0%) with BMIs between 30 and 39.9 received the correct
“obesity” designation by ICD-9 code (Figure 2). This equates to an ICD-9 code
sensitivity of 0.19, with specificity and positive and negative predictive values of 0.97,
0.70, and 0.76, respectively (Figure 3). Only 14 patients were assigned the more specific
ICD-9 code V85.3 without code 278.00. When V85.3 was included with 278.00,
sensitivity, specificity, and positive and negative predictive values were 0.21, 0.97, 0.72,
and 0.76, respectively.
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Figure 1: Bar graph depicting patients by BMI decile, based on calculated BMI. These bars are broken
down to indicate the coding associated with the patients in each bar (no obesity ICD-9 code, “obesity”
ICD-9 code (278.00), or “morbid obesity” ICD-9 code (278.01)). Figure 1a uses percent of the population
studied as the y axis. Figure 1b uses percent of patients for a given BMI decile as the y axis (to allow better
visualization of the components of the smaller bars in figure 1a).
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Figure 2: Bar graph depicting the percent of all patients by specific BMI decile, based on calculated BMI.
Included within each bar is the portion of patients who received a correct obesity-related ICD-9 code (no
code for those with a BMI < 30; 278.00 for those with a BMI of 30-40; 278.01 for those with a BMI >40)
or an incorrect or missing obesity-related ICD-9 code.

Of the 104 patients who received ICD-9 code 278.01 (“morbid obesity”), 84 had a
true BMI of 40 or greater, while 20 of these patients had miscoded BMIs outside of this
range (Figure 1). 4 miscoded patients had a BMI below 30, and 16 had a BMI between
30-39.9. Thus, only 84 of the 174 patients (48.2%) with BMIs over 40 received the
correct “morbid obesity” designation by ICD-9 code (Figure 2). This equates to ICD-9
code sensitivity, specificity, and positive and negative predictive values of 0.48, 0.99,
0.81, and 0.96, respectively (Figure 4). Only 11 patients were assigned the more specific
ICD-9 code V85.4 without code 278.01. When V85.4 was included with 278.01,
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sensitivity, specificity, and positive and negative predictive values were 0.54, 0.99, 0.82,
and 0.96, respectively.

Figure 3: Chart showing the sensitivity, specificity, positive predictive value, and negative predictive value
of ICD-9 Code 278.00 (“Obesity, unspecified”) compared to calculated BMI.
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Figure 4: Chart showing the sensitivity, specificity, positive predictive value, and negative predictive value
of ICD-9 Code 278.01 (“Morbid Obesity”) compared to calculated BMI.

Anemia
In total, 286 patients were initially identified as part of this cohort. Of these, 24
(8.3%) were excluded due to trauma, and 2 (0.7%) were excluded for lack of a
preoperative CBC. This left 260 spine surgery patients, of which 151 (58.1%) were
female and 109 (41.9%) were male. The cohort included 120 (46.2%) cervical fusion
patients and 140 (53.8%) lumbar fusion patients. Patient demographics can be found in
Table 2.
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Table 2: Demographics of the patient population for the anemia arm of the present study
Overall
Sex
Female
Male
Age (years)
< 39
40-49
50-59
60-69
70-79
> 80
Spine Fusion
Cervical
Lumbar

Number
260

Percent
100%

151
109

58.1%
41.9%

38
55
69
62
26
10

14.6%
21.5%
27.0%
24.2%
10.2%
3.9%

120
140

46.2%
53.9%

The average hematocrit of all patients was 41.6 ± 4.2%. Overall, 37 patients
(14.2%) were anemic by definition. That is, 16 female patients (6.2% of the study
population) had a preoperative hematocrit that was lower than 36.0%, and 21 male
patients (8.1% of the study population) had a preoperative hematocrit that was lower than
41.0%.
Ten of the 260 total patients (3.8%) received an “anemia” ICD-9 code. Figures 5
and 6 show the distribution of preoperative hematocrits in the coded versus not-coded
groups, relative to the normal hematocrit range for each gender. Of patients receiving an
“anemia” ICD-9 code, 7 patients truly had anemia by definition, while 3 had normal
hematocrits, and thus were miscoded. Thus, only 7 of the 37 patients (18.9%) with true
anemia received the correct “anemic” designation by ICD-9 code. This equates to an
ICD-9 code sensitivity of 19% (95% confidence interval [CI] = 6.3% to 31.5%), with
specificity and positive and negative predictive values of 99% (95% CI = 97.1% to
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100.0%), 70% (95% CI = 41.6% to 98.4%), and 88% (95% CI = 84.0% to 92.0%),
respectively (Figure 7).

Figure 5: Box and whisker plot depicting the preoperative hematocrits of female patients. The x-axis
shows female patients who were not assigned an anemia ICD-9 code upon discharge versus those who were
assigned an anemia ICD-9 code. The three horizontal lines of the box represent the first quartile, median,
and third quartile, respectively, while the whiskers of the plot extend to the minimum and maximum values
of the cohort.
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Figure 6: Box and whisker plot depicting the preoperative hematocrits of male patients. The x-axis shows
male patients who were not assigned an anemia ICD-9 code upon discharge versus those who were
assigned an anemia ICD-9 code. The three horizontal lines of the box represent the first quartile, median,
and third quartile, respectively, while the whiskers of the plot extend to the minimum and maximum values
of the cohort.
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Figure 7: The sensitivity, specificity, positive predictive value, and negative predictive value of anemia
ICD-9 coding compared to chart-documented hematocrit.

Discussion
The use of administratively coded national databases for orthopaedic surgery
research continues to increase. Though database use has many advantages, each dataset
carries its own unique set of benefits and limitations. One pressing concern in particular
is in regards to the clinical accuracy of the administrative ICD-9 diagnosis codes from
which many databases are assembled.9,10,12,13,20,21,23 Unfortunately, without close
knowledge of each major database and data element, it can be difficult for the reader to
determine whether a given study presents valid results to the questions being
investigated. This study uses the easily quantifiable example comorbidities of obesity and
anemia to clarify the relationship between administrative ICD-9 discharge codes and
clinical reality, as well as to examine the ensuing possible consequences on research
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studies in medicine and orthopaedic surgery that employ administrative databases as a
data source.

Obesity
The results of the first segment of this study indicate that administratively coded
ICD-9 diagnosis codes do not accurately represent whether a patient is obese. For patients
with “non-morbid obesity” (BMI 30-39.9) just 19% of patients were correctly deemed
obese by ICD-9 code. While patients with “morbid obesity” (BMI > 40) were more
accurately coded, still just 48% of patients received the correct ICD-9 code. These results
align with the remarkably low obesity-related coding accuracy found by the
aforementioned published studies in specialized cohorts of obstetric and pediatric
patients.20-23 Though ICD-9 codes in the present study were very specific for both the
non-morbid obesity and morbid obesity categories at 0.97 and 0.99, respectively, they
exhibited low sensitivities of 0.19 and 0.48.
We are concerned by these results. By using obesity as an example, this study
exposes a significant limitation of conducting research with national databases built upon
ICD-9 coding data. While ICD-9 codes are of reasonable utility, they are coded for
administrative and billing purposes and may not capture the quality of data desired for
research purposes.
Numerous prior studies from the orthopaedic surgery literature have used ICD-9coded databases like the NIS to draw conclusions about obesity and patient pathology,
approximate national obesity rates, and adjust for obesity in multivariable analyses.27,43-46
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However, the reported obesity rates in these investigational cohorts were 1.6%,44 3.2%,45
3.7%,45 and 7%,46 to list a few. In fact, the highest reported obesity rate we were able to
find in a study using the NIS database was 15%.47 This sharply contrasts with both the
current estimate of adult obesity rates in the United States of 35.7% established by the
Centers for Disease Control and Prevention (CDC),48 as well as the 36.0% obesity rate
identified by direct calculation in our study population. While many of the quoted studies
analyzed specific patient subsets that could conceivably have somewhat different obesity
rates compared to the general population or a hospital census, we find it unlikely that
these populations would have obesity rates that so dramatically differ from national
estimates.
Equally troubling, this trend of severely undercoding obesity rates with ICD-9
codes persists outside of the field of orthopaedic surgery. We discovered several
published studies documenting obesity rates of 3.1%,49 3.8%,25 6.8%,26 and 7.6%50 in
various medical fields such as cardiology, general surgery, and nephrology. While these
are all specialized populations, (e.g., patients with nephrolithiasis or coronary artery
disease), we believe it to be unlikely that the above-stated NIS cohorts carry obesity rates
that so dramatically differ from the national average.
Is it acceptable to believe that just 12% of patients undergoing total knee
arthroplasty (TKA) are obese,51 particularly when obesity is a known contributor to early
knee arthritis?52-55 Or, similarly, that only 7.6%50 of patients undergoing coronary artery
bypass grafting are obese, again when it is well known that obesity is a risk factor for the
development of coronary artery disease?56-58 If we intend to draw meaningful clinical
conclusions from database research, these significant disparities must first be taken into
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account. Perhaps even more worrisome, the majority of these previous studies rarely
mention their considerably discordant obesity rates and, if they do, only briefly note
possible coding inaccuracies in their limitations sections. While this tremendous
limitation is perhaps unknown to study authors, ongoing database publications are at risk
of drawing conclusions based on fundamentally flawed source data. This is particularly
concerning given the high rate at which database studies are currently being published in
the literature.
Take the example of non-morbid obesity in our present analysis. In this case, any
ICD-9-based conclusions would be drawn from a mere 19% of the intended obese
population, with remaining obese patients incorrectly grouped into non-obese cohorts.
This means that for every five obese patients an investigator expects to include, only one
actually enters the analysis, an exclusion rate that would be unacceptable in any other
study design. This raises serious concerns regarding the validity of studies conducted in
this fashion.
Furthermore, there is a potential selection bias to this ICD-9 coding inaccuracy, as
there may be additional unknown factors causing this 19% of obese patients to be coded
as such while omitting the rest. For example, it is possible that this 19% is the sickest
fraction of obese patients, whose care was so complicated by body habitus that the
patient’s obesity was unmistakable to those providing patient care, as well as to those
assigning codes upon discharge. This is supported by the higher sensitivity of ICD-9
codes for morbidly obese patients (48%), as their morbid obesity was likely more prone
to influence their hospitalization, perhaps leading to the increased accuracy of coding
compared to non-morbid obesity. In light of this, researchers using ICD-9-coded
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databases may be drawing conclusions about the most extreme effects of obesity, rather
than developing the intended and more useful collective representation of this important
cohort.

Anemia
The results of the second arm of the current study demonstrate the inability of
administrative ICD-9 discharge diagnosis codes to accurately document whether a patient
is anemic prior to surgery. Only 10 of the 260 patients received an ICD-9 code indicating
anemia, 7 of whom were truly anemic based on preoperative hematocrit, and 3 of whom
had normal hematocrits. However, 37 patients were deemed to be truly anemic based on
preoperative hematocrit, meaning just 19% of anemic patients were correctly identified
by ICD-9 code.
These results mirror those of the previously mentioned studies that examined the
ICD-9 coding accuracy of other comorbidities,8,20 as well as the obesity arm of the
present study. Although the ICD-9 codes in the current study were very specific at 99%,
the sensitivity was quite low at 19%, with a positive and negative predictive value of 70%
and 88%, respectively.
These results are troubling, as they further demonstrate an important limitation of
using ICD-9-coded databases for scientific research. Many published studies from the
orthopaedic surgery literature have used ICD-9-coded databases, such as the NIS, to
examine relationships between preoperative anemia and various surgical spinal
disorders.34-42 For example, preoperative anemia has been stated to be correlated with
reintubation following anterior cervical fusion, perioperative visual loss following spinal
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fusion, and a significantly increased risk of deep vein thrombosis and pulmonary
embolism following lumbar spine surgery.38,40,41 However, the current study indicates
that these anemia codes, originally developed for the purposes of reimbursement and
billing, may not capture the quality of data necessary for making such clinical
conclusions.
As a field, orthopaedic surgery is entering an era in which it must become more
aware of the limitations of administratively coded database research. As further studies
continue to delineate the substantial inaccuracies of ICD-9 codes, it is becoming clear
that ongoing database studies are at risk of using a flawed data source. Many publications
only briefly mention this considerable limitation, an understatement that is especially
concerning given the high usage of administrative databases in the field of orthopaedic
surgery research.
Through the example of preoperative anemia in our present analysis, we show
that any conclusions about anemia based on ICD-9 data from this single medical center
would be drawn from a mere 19% of the intended anemic population, with remaining
anemic patients incorrectly grouped into normal cohorts. This is similar to the 19% ICD9 coding accuracy found previously for the comorbidity of obesity. In both examples, this
would equate to an exclusion rate of 81% of patients, a percentage that would be
unacceptable in any other study design. An exclusion rate of 81% subjects the remaining
study cohort to tremendous bias, as there are most certainly additional unidentified
characteristics causing the 19% of correctly identified anemic patients to be coded
accurately.
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In an attempt to determine a unifying characteristic of this cohort, the hematocrit
range for those who were coded versus those who were not was plotted in both males and
females (Figures 5 and 6). These figures demonstrate a slight trend indicating those with
the lowest hematocrits were more frequently coded for anemia, however this trend cannot
be definitively stated.

Future considerations
As introduced previously, both obesity and anemia were chosen as variables for
this analysis because of their readily quantifiable and continuous nature. However,
because this study suggests ICD-9 codes are unable to adequately identify obesity and
anemia in hospitalized patients, we must question if other comorbidities (e.g.,
hypertension, diabetes, coagulopathy) fall subject, at least in part, to similar coding
issues.
Additional comorbidities were not presently evaluated primarily because they
lack a consistently quantifiable gold standard for comparison to ICD-9 coding data. As an
example, would it be most appropriate to compare an ICD-9 discharge code for a patient
with diabetes to that patient’s hemoglobin A1c? Or would a better comparison be
between the ICD-9 code and a fasting glucose on the day of discharge? Furthermore, how
would researchers best account for any medications a patient may be taking and the way
that might affect such measurements? Similar questions can be raised for comorbidities
such as hypertension and hyperlipidemia.
However, a study that develops a standardized method for scrutinizing additional
variables would be a logical next step for investigation. Though some previous analyses
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have been conducted on additional comorbidities,10,13 these were done retrospectively and
thus rely on the same medical record review as ICD-9 data. In contrast, obesity and
anemia have readily available gold standard BMI and hematocrit data that is routinely
entered for each patient, allowing a retrospective review without the corresponding bias.
Validation of other comorbidities that lack such an objective gold standard may require
prospective studies in the future.

ICD-10
Another important consideration related to this study is the approaching
nationwide implementation of the International Classification of Diseases Tenth Revision
(ICD-10). In the coming months and years, hospital systems across the United States will
be required to begin implementing the ICD-10 system of codes as a replacement for the
ICD-9 codes. ICD-10 has already been in use across the world for several years, giving
us an idea of the benefits and pitfalls that might accompany this transition in the United
States.
ICD-10 is being implemented with the idea of shifting healthcare across the globe
to a coding system that is both universal and more precise than previous methods. ICD10 is far more granular and specific than its predecessor, a characteristic that is intended
to decrease medical errors, enhance healthcare delivery, and improve the reporting of
healthcare data. However, these lofty goals do not come without difficulties. Several
forecasted barriers to the new implementation include the immense amount of required
planning, the monetary cost of conversion, a temporary shortage of coders qualified to
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assign the new ICD-10 codes, and the initial loss of productivity and efficiency
associated with the re-training of coders, physicians, and staff.
Because ICD-10 has been in widespread use for several years in many areas
outside of the United States, many studies have already been conducted analyzing the
relative successes and failures of the new system. With regards to the early benefits that
have been investigated, a recent study out of Denmark evaluated the accuracy of ICD-10
diagnosis codes for each of the nineteen comorbidities that make up the Charlson
comorbidity index (CCI).59 The Charlson comorbidity index is a predictive scoring
system of ten-year mortality that is made up of nineteen comorbidities, each assigned a
designated number of points.60 It is often considered to be similar to, but more precise
than, the American Society of Anesthesiologists (ASA) score. The study authors used
950 patients from the Danish National Registry of Patients to evaluate the sensitivity and
positive predictive values of ICD-10 codes for all nineteen Charlson comorbidities. The
least accurate ICD-10 codes were 82.0% accurate, while the best were 100%. The
average for all conditions was 98% sensitivity, with eighteen of the nineteen conditions
greater than 90%. This study was conducted four years after the implementation of ICD10 in Denmark, indicating that there is great potential for high quality data capture with
ICD-10, once the system has been established and functioning for several years.
Further studies evaluating the accuracy of ICD-10 codes around the world haven’t
been quite as clear-cut. As an example, a different study out of Denmark investigated the
accuracy of the ICD-10 code for syncope in inpatient and emergency department visits.
In this study, they found that this code was only sensitive to 62.7%.61 While this is not
nearly as strong as the ICD-10 codes for Charlson comorbidities addressed above by a
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different Danish study in which most comorbidities were greater than 90% sensitive, this
still represents a sensitivity that is far better than the ICD-9 code sensitivities discovered
in the present study for non-morbid obesity, morbid obesity, and anemia. Similarly, a
study by Henderson et al. out of Australia evaluated the quality of data collection by
ICD-10 codes for a number of comorbidities. This analysis produced a range of
sensitivities, varying from 62% (peripheral vascular disease) to 94% (metastatic
neoplasms).62 Again, while these vary in quality, they all far exceed the ICD-9 code
sensitivities found in the present study.
Finally, various emerging studies indicate that for some data elements, ICD-10
coding still falls victim to significant inaccuracies. In a recent study from Australia,
investigators looked at the ability of ICD-10 codes to accurately document such variables
as sepsis, cholecystitis, viscous perforation, peritonitis, and pneumonia. For these
elements, ICD-10 sensitivities were as low as 7.1%, 4.3%, 10.6%, 2.0%, and 13.8%,
respectively in one hospital system, and 16.5%, 2.4%, 13.0%, 0.4%, and 11.8%,
respectively in a separate hospital system.63 These are alarmingly low sensitivities and
perhaps indicate specific variables for which ICD-10 coding is not well suited. While it
was not indicated in the study how long the hospital systems had been using ICD-10
coding, the study period spanned six years, suggesting these low sensitivities were likely
not a result of the “learning curve” that would be associated with the early stages of the
transition from ICD-9 to ICD-10.
With regards to this so-called “learning curve,” a prior study looked to see if this
truly exists and whether ICD-10 coding quality changes over time.64 This was a study
performed in Switzerland and was conducted by randomly selecting 3,500 patients from
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three different hospitals at two year intervals (1999, 2001, 2003). In these patients, the
study authors evaluated the accuracy of ICD-10 coding for seventeen Charlson index
comorbidities and twenty-nine Elixhauser index comorbidities. As a whole, ICD-10
coding sensitivity for the Charlson comorbidities steadily increased from 36.5% to 42.5%
to 42.8%. In the Elixhauser group, coding sensitivity increased from 34.2% to 38.6% to
41.6%. On an individual scale, ICD-10 coding sensitivity increased for thirty of thirty-six
total comorbidities and decreased for ten of thirty-six comorbidities. While overall, we
make the case that these sensitivities would be considered rather poor, particularly for
research use as part of a national database, it is encouraging that ICD-10 coding
sensitivities showed the capacity in this study to improve in quality over time.
Though it is still unclear exactly how ICD-10 will work out compared to ICD-9, it
is already showing promising signs of establishing itself as an upgrade to the previous
system. A main goal of ICD-10 was to increase the accuracy of coding, coming in the
form of thousands of new codes able to capture diagnoses and procedures at a more
granular level than ever before. While it in fact does appear in the early stages that ICD10 is accomplishing its goal of increased coding accuracy, it is yet unclear whether this
accuracy will be high enough to make the data suitable for research purposes. In the
coming years as ICD-10 is implemented in the United States, it will be of paramount
importance to evaluate the coding accuracies of the new system, much in the same way as
the present study. Studies such as these will aid in determining whether national
databases constructed from new ICD-10 discharge codes are appropriate for research
usage.
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Administrative considerations
A final implication of the findings in the current study is the effect such
inaccuracies in ICD-9 coding have on the administrative and billing aspects of healthcare
in the United States. This has not been previously discussed in this paper, as this study
was conducted to evaluate ICD-9 codes as they pertain to research purposes, rather than
billing purposes. However, a brief discussion of this separate but similarly important
aspect of ICD-9 coding is appropriate.
With the rollout of ICD-10 as a replacement for ICD-9 codes, one of the principal
purposes of this implementation was to increase the accuracy of payment data, decrease
the number of unpaid claims, and decrease payment fraud within the healthcare system.6567

Beginning with the advent of diagnosis related groups (DRGs) in the 1980s, hospitals

now bill based on the complexity of a given patient’s hospital stay. As would be
expected, comorbidities such as obesity and anemia contribute to a patient’s hospital visit
complexity and associated hospital charges. One can imagine, if a hospital is only
identifying 19% of non-morbidly obese patients, 48% of morbidly obese patients, and
19% of anemic patients, there is a tremendous amount of ‘waste’ in the system for which
the hospital is not charging for inpatient stays. This generally translates into higher profit
margins for insurance companies and decreased payment to healthcare providers.65,66 Not
only that, but with such inaccurate coding, it presents a significant challenge to those
examining methods by which to control healthcare costs.65 How can cost control
measures truly be implemented without an accurate knowledge of where costs originate
in the first place? Poor ICD-9 coding obscures national trends in healthcare requirements
and delivery. A final consideration regarding the ICD-9 code findings of the current study
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is the void that remains for fraud within the system. With such inaccurate coding of
comorbidities, there is no clear idea of the true cost of a given hospital visit, thus
increasing the potential for fraudulent billing practices.67 Each of these elements
concerning the administrative and billing components of the United States healthcare
system further strengthen the case that the current inaccuracies of ICD-9 discharge codes
are cause for great concern.

Limitations
This investigation has its limitations. The study was performed at one hospital
system, so the findings may not apply to all hospitals in a given database. However,
because the Yale-New Haven hospital system contributes data to many national
databases, we believe it to be a clinically relevant sample. Moreover, as an example, our
hospital population had an obesity rate of 36.0% compared to reported CDC rates of
35.7%.
Another limitation specific to the obesity arm relates to the argument that
assigning the ICD-9 code 278.00 (“Obesity, unspecified”) to patients with a BMI over 40
is not necessarily incorrect, as occurred in 32 (1.5%) patients. That being said, previous
studies that used administrative databases to examine both obesity and morbid obesity as
separate variables have consistently used the “Obesity, unspecified” code to identify
patients with BMIs of 30-39.9, reserving the “Morbid obesity” code for those with a BMI
over 40.27,43 Because of this historical pattern, we attempted to be consistent with prior
studies in our evaluation of these ICD-9 discharge codes. Similarly, we acknowledge that
the ICD-9 codes V85.3 and V85.4 also exist as a secondary method to document a
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patient’s specific BMI, though these are rarely used in the existing literature.12,51
Nevertheless, including V85.3 for non-morbid obesity and V85.4 for morbid obesity in
the overall analysis only marginally increased the ICD-9 code sensitivities, to 0.21 and
0.54, respectively.
Similarly, a limitation specific to the anemia arm relates to the ICD-9 codes that
were used for comparison. The authors attempted to compare preoperative hematocrit
values with the same ICD-9 discharge codes that would be used to generate the
comorbidity variable of “anemia,” based on what has been outlined previously by the
NIS. We realized that it is certainly possible that other administratively coded databases
use alternative combinations of ICD-9 discharge codes in order to determine a diagnosis
of anemia. The NIS was chosen because of its current prolific use in medical and
orthopaedic surgery research.

Conclusion
In light of the orthopaedic surgery community’s increasing reliance on large
national databases, it is important to consider the data source. As demonstrated by this
study of obesity and anemia, ICD-9 coding is prone to significant inaccuracies that we
argue are too great to be acceptable for research-quality data. These disparities have the
potential to sway patient management, alter treatment decisions, and propagate
potentially inaccurate conclusions in the literature.
Though not the primary focus of the current study, these findings also have
significant implications for billing and administrative entities within the United States
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healthcare system. As we look to the coming years and the impending implementation of
the ICD-10 coding system, there is emerging evidence that the quality of ICD-10 coding
will be an improvement over the current ICD-9 system. However, it remains to be seen
whether the data will be of sufficient quality for research purposes. Until then, though
database research is a powerful tool, we must be careful to fully understand the quality of
the data elements we use in order to reach meaningful conclusions. In this way, we will
better capitalize on the power of database research to improve our knowledge and
practice of orthopaedic surgery.
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